Hisamitsu Pharmaceutical Co Inc

HPX

Company Profile

  • Business description

    Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

  • Contact

    408 Tashiro Daikan-machi
    Tosu
    Saga841-0017
    JPN

    T: +81 942832101

    http://www.hisamitsu.co.jp

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    28 February 2025

    Employees

    3,682

Stocks News & Analysis

stocks

Best and worst performing ASX sectors of 2024

Exploring the ASX sectors that moved the market this year.
stocks

2 ASX companies with the traits of a long-term winner

Two companies that show promising signs of handsomely rewarding shareholders.
video

Our outlook for 2025

Morningstar Equity Market Strategist Lochlan Halloway discusses his view on what we can expect in markets in 2025. 

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,465.0044.500.53%
CAC 407,393.7613.020.18%
DAX 4020,024.66115.520.58%
Dow JONES (US)42,392.27151.95-0.36%
FTSE 1008,260.0987.071.07%
HKSE19,623.32436.63-2.18%
NASDAQ19,280.7930.00-0.16%
Nikkei 22539,894.54386.62-0.96%
NZX 50 Index13,104.376.37-0.05%
S&P 5005,868.5513.08-0.22%
S&P/ASX 2008,201.2042.100.52%
SSE Composite Index3,262.5689.20-2.66%

Market Movers